Role of SUMOylation in Regulation of TGF-β Signaling Pathway

Yong Xu

2012-01-01

Abstract:The small ubiquitin-related modifier(SUMO) is a small ubiquitin-like molecule.It can covalently attach to lysine residues of target proteins.This process is referred to SUMOylation,which has a wide range of biological functions.SUMO can regulate the transforming growth factor-β(TGF-β) pathway by modifying some important signaling molecules through SUMOylation.

What problem does this paper attempt to address?

The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells

Xiaoxia Shi,Yixin Du,Shujing Li,Huijian Wu

DOI: https://doi.org/10.3390/ijms23073639

IF: 5.6

2022-01-01

International Journal of Molecular Sciences

Abstract:Small ubiquitin-like modifier (SUMO)ylation is a reversible post-translational modification that plays a crucial role in numerous aspects of cell physiology, including cell cycle regulation, DNA damage repair, and protein trafficking and turnover, which are of importance for cell homeostasis. Mechanistically, SUMOylation is a sequential multi-enzymatic process where SUMO E3 ligases recruit substrates and accelerate the transfer of SUMO onto targets, modulating their interactions, localization, activity, or stability. Accumulating evidence highlights the critical role of dysregulated SUMO E3 ligases in processes associated with the occurrence and development of cancers. In the present review, we summarize the SUMO E3 ligases, in particular, the novel ones recently identified, and discuss their regulatory roles in cancer pathogenesis.
Protein modification by SUMO.

Erica S. Johnson

DOI: https://doi.org/10.1146/ANNUREV.BIOCHEM.73.011303.074118

IF: 27.258

2004-06-09

Annual Review of Biochemistry

Abstract:Small ubiquitin-related modifier (SUMO) family proteins function by becoming covalently attached to other proteins as post-translational modifications. SUMO modifies many proteins that participate in diverse cellular processes, including transcriptional regulation, nuclear transport, maintenance of genome integrity, and signal transduction. Reversible attachment of SUMO is controlled by an enzyme pathway that is analogous to the ubiquitin pathway. The functional consequences of SUMO attachment vary greatly from substrate to substrate, and in many cases are not understood at the molecular level. Frequently SUMO alters interactions of substrates with other proteins or with DNA, but SUMO can also act by blocking ubiquitin attachment sites. An unusual feature of SUMO modification is that, for most substrates, only a small fraction of the substrate is sumoylated at any given time. This review discusses our current understanding of how SUMO conjugation is controlled, as well as the roles of SUMO in a number of biological processes.

Biology,Medicine
Signalling mechanisms and cellular functions of SUMO

Alfred C. O. Vertegaal

DOI: https://doi.org/10.1038/s41580-022-00500-y

IF: 113.915

2022-06-25

Nature Reviews Molecular Cell Biology

Abstract:Sumoylation is an essential post-translational modification that is catalysed by a small number of modifying enzymes but regulates thousands of target proteins in a dynamic manner. Small ubiquitin-like modifiers (SUMOs) can be attached to target proteins as one or more monomers or in the form of polymers of different types. Non-covalent readers recognize SUMO-modified proteins via SUMO interaction motifs. SUMO simultaneously modifies groups of functionally related proteins to regulate predominantly nuclear processes, including gene expression, the DNA damage response, RNA processing, cell cycle progression and proteostasis. Recent progress has increased our understanding of the cellular and pathophysiological roles of SUMO modifications, extending their functions to the regulation of immunity, pluripotency and nuclear body assembly in response to oxidative stress, which partly occurs through the recently characterized mechanism of liquid–liquid phase separation. Such progress in understanding the roles and regulation of sumoylation opens new avenues for the targeting of SUMO to treat disease, and indeed the first drug blocking sumoylation is currently under investigation in clinical trials as a possible anticancer agent.

cell biology
Key Role for Ubiquitin Protein Modification in TGFβ Signal Transduction

Miriam de Boeck,Peter ten Dijke

DOI: https://doi.org/10.3109/03009734.2012.654858

2012-01-01

Upsala Journal of Medical Sciences

Abstract:The transforming growth factor b (TGFb) superfamily of signal transduction molecules plays crucial roles in the regulation of cell behavior.TGFb regulates gene transcription through Smad proteins and signals via non-Smad pathways.The TGFb pathway is strictly regulated, and perturbations lead to tumorigenesis.Several pathway components are known to be targeted for proteasomal degradation via ubiquitination by E3 ligases.Smurfs are well known negative regulators of TGFb, which function as E3 ligases recruited by adaptors such as I-Smads.TGFb signaling can also be enhanced by E3 ligases, such as Arkadia, that target repressors for degradation.It is becoming clear that E3 ligases often target multiple pathways, thereby acting as mediators of signaling cross-talk.Regulation via ubiquitination involves a complex network of E3 ligases, adaptor proteins, and deubiquitinating enzymes (DUBs), the last-mentioned acting by removing ubiquitin from its targets.Interestingly, also non-degradative ubiquitin modifications are known to play important roles in TGFb signaling.Ubiquitin modifications thus play a key role in TGFb signal transduction, and in this review we provide an overview of known players, focusing on recent advances.
Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4*

X Lin,M Liang,YY Liang,FC Brunicardi,F Melchior,XH Feng

DOI: https://doi.org/10.1074/jbc.m302243200

IF: 5.485

2003-01-01

Journal of Biological Chemistry

Abstract:Smads are important intracellular effectors in signaling pathways of the transforming growth factor-beta (TGF-beta) superfamily. Upon activation by TGF-beta, receptor-phosphorylated Smads form a complex with tumor suppressor Smad4/DPC4, and the Smad complexes then are imported into the nucleus. Although diverse pathways regulate the activity and expression of receptor-phosphorylated and inhibitory Smads, cellular factors modulating the activity of the common Smad4 remain unidentified. Here we describe the involvement of the small ubiquitin-like modifier-1 (SUMO-1) conjugation pathway in regulating the growth inhibitory and transcriptional responses of Smad4. The MH1 domain of Smad4 was shown to associate physically with Ubc9, the ubiquitin carrier protein (E2) conjugating enzyme in sumoylation. In cultured cells, Smad4 is modified by SUMO-1 at the endogenous level. The sumoylation sites were identified as two evolutionarily conserved lysine residues, Lys-113 and Lys-159, in the MH1 domain. We found that the mutations at Lys-113 and Lys-159 did not alter the ability of Smad4 to form a complex with Smad2 and FAST on the Mix.2 promoter. Importantly, SUMO-1 overexpression enhanced TGF-beta-induced transcriptional responses. These findings identify sumoylation as a unique mechanism to modulate Smad4-dependent cellular responses.
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

Feng Xie,Zhengkui Zhang,Hans van Dam,Long Zhang,Fangfang Zhou

DOI: https://doi.org/10.3390/cells3040981

IF: 6

2014-01-01

Cells

Abstract:TGF-β(transforming growth factor-β) superfamily signaling mediators are important regulators of diverse physiological and pathological events. TGF-β signals are transduced by transmembrane type I and type II serine/threonine kinase receptors and their downstream effectors, the SMAD(drosophila mothers against decapentaplegic protein) proteins. Numerous studies have already demonstrated crucial regulatory roles for modification of TGF-β pathway components by poly-ubiquitination. Recently, several studies also uncovered mono-ubiquitination of SMADs as a mechanism for SMAD activation or inactivation. Mono-ubiquitination and subsequent deubiquitination of SMAD proteins accordingly play important roles in the control of TGF-β superfamily signaling. This review highlights the major pathways regulated by SMAD mono-ubiquitination.
Regulation of Smad Functions Through Ubiquitination and Sumoylation Pathways

Xin-Hua Feng,Xia Lin

DOI: https://doi.org/10.1007/1-4020-4709-6_13

2006-01-01

Abstract:Post-translational modifications by the ubiquitin and ubiquitin-like pathways have recently emerged as common mechanisms to regulate the turnover and functions of many transcription factors. Improper modifications of these regulatory proteins may play an important role in the initiation and/or progression of human diseases. Recent evidence suggests that stability, activity and signaling strength of Smads are fine-tuned via various post-translational modifications including, ubiquitination and sumoylation. Critical functions of the modifications are underscored by their functional consequence in TGF-β antiproliferative and transcriptional responses. Thus the modification of Smads may control diverse developmental processes and the pathogenesis of many diseases including cancer, autoimmune diseases, and fibrotic diseases. In this chapter, we will focus on the functions and underlying mechanisms of ubiquitin and SUMO modifications on Smads
The Emerging Roles of SUMOylation in the Tumor Microenvironment and Therapeutic Implications

Yunru Gu,Yuan Fang,Xi Wu,Tingting Xu,Tong Hu,Yangyue Xu,Pei Ma,Qiang Wang,Yongqian Shu

DOI: https://doi.org/10.1186/s40164-023-00420-3

2023-01-01

Abstract:Tumor initiation, progression, and response to therapies depend to a great extent on interactions between malignant cells and the tumor microenvironment (TME), which denotes the cancerous/non-cancerous cells, cytokines, chemokines, and various other factors around tumors. Cancer cells as well as stroma cells can not only obtain adaption to the TME but also sculpt their microenvironment through a series of signaling pathways. The post-translational modification (PTM) of eukaryotic cells by small ubiquitin-related modifier (SUMO) proteins is now recognized as a key flexible pathway. Proteins involved in tumorigenesis guiding several biological processes including chromatin organization, DNA repair, transcription, protein trafficking, and signal conduction rely on SUMOylation. The purpose of this review is to explore the role that SUMOylation plays in the TME formation and reprogramming, emphasize the importance of targeting SUMOylation to intervene in the TME and discuss the potential of SUMOylation inhibitors (SUMOi) in ameliorating tumor prognosis.
Sumoylation Enhances the Activity of the TGF-β/SMAD and HIF-1 Signaling Pathways in Keloids

Xiaohu Lin,Yuming Wang,Yan Jiang,Mingyuan Xu,Qianqian Pang,Jiaqi Sun,Yijia Yu,Zeren Shen,Rui Lei,Jinghong Xu

DOI: https://doi.org/10.1016/j.lfs.2020.117859

IF: 6.78

2020-01-01

Life Sciences

Abstract:Excessive fibrosis and extracellular matrix deposition resulting from upregulation of target genes expression mediated by transforming growth factor-beta (TGF-β)/SMAD and hypoxia inducible factor-1 (HIF-1) signaling pathways are the main mechanisms that drive keloid formation. Sumoylation is a protein posttranslational modification that regulates the function of proteins in many biological processes. In the present study, we aimed to investigate the mechanism underlying the effects of sumoylation on the TGF-β/SMAD and HIF-1 signaling pathways in keloids. We used 2-D08 to block sumoylation and silenced the expression of sentrin sumo-specific protease 1 (SENP1) to enhance sumoylation in human foreskin fibroblasts (HFFs) and human keloid fibroblasts (HKFs). We also reduced and increased intracellular SUMO1 levels by silencing SUMO1 and transfecting cells with a SUMO1 overexpression lentivirus, respectively. Sumoylation has the ability to amplify TGF-β/SMAD and HIF-1 signals in keloids, while SUMO1, especially the SUMO1-RanGAP1 complex, is the key molecule affecting the TGF-β/SMAD and HIF-1 signaling pathways. In addition, we also found that hypoxia promotes sumoylation in keloids and that HIF-1α is covalently modified by SUMO1 at Lys 391 and Lys 477 in HKFs. In summary, we elucidated the role and molecular mechanism of sumoylation in the formation of keloids, providing a new perspective for a potential therapeutic target of keloids.
DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

c j huang,d wu,ahmed khan f,l j huo

DOI: https://doi.org/10.1089/dna.2015.2933

2015-01-01

DNA and Cell Biology

Abstract:The discovery of the process of small ubiquitin-like modifier (SUMO)-mediated post-translational modification of targets (SUMOylation) in early 1990s proved to be a significant step ahead in understanding mechanistic regulation of proteins and their functions in diverse life processes at the cellular level. The critical step in reversing the SUMOylation pathway is its ability to be dynamically deSUMOylated by SUMO/sentrin-specific protease (SENP). This review is intended to give a brief introduction about the process of SUMOylation, different mammalian deSUMOylating enzymes with special emphasis on their regulation of ribosome biogenesis at the molecular level, and its emerging roles in mitochondrial dynamics that might reveal usefulness of SENPs for therapeutic applications.
Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Linlin Fan,Xudong Yang,Minying Zheng,Xiaohui Yang,Yidi Ning,Ming Gao,Shiwu Zhang

DOI: https://doi.org/10.3389/fonc.2022.943683

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:Wnt/β-catenin signaling is a delicate and complex signal transduction pathway mediated by multiple signaling molecules, which plays a significant role in regulating human physiology and pathology. Abnormally activated Wnt/β-catenin signaling pathway plays a crucial role in promoting malignant tumor occurrence, development, recurrence, and metastasis, particularly in cancer stem cells. Studies have shown that the Wnt/β-catenin signaling pathway controls cell fate and function through the transcriptional and post-translational regulation of omics networks. Therefore, precise regulation of Wnt/β-catenin signaling as a cancer-targeting strategy may contribute to the treatment of some malignancies. SUMOylation is a post-translational modification of proteins that has been found to play a major role in the Wnt/β-catenin signaling pathway. Here, we review the complex regulation of Wnt/β-catenin signaling by SUMOylation and discuss the potential targets of SUMOylation therapy.
Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

Katarzyna C. Masoumi,Gemma Marfany,Yingli Wu,Ramin Massoumi

DOI: https://doi.org/10.2217/fon.15.320

2016-01-01

Future Oncology

Abstract:Deubiquitinating enzymes (DUBs) are specialized proteins that can recognize ubiquitinated proteins, and after direct interaction, deconjugate monomeric or polymeric ubiquitin chains, thus changing the fate of the substrates. This process is instrumental in mediating or changing downstream signaling pathways. Beside mutations and alterations in their expression levels, the activity and stability of deubiquitinating enzymes is vital for their function. SUMOylations consist of the conjugation of the small peptide SUMO to protein substrates which is very similar to ubiquitination in the mechanistic and machinery required. In this review, we will focus on how SUMOylation can regulate DUB enzymatic activity, stability or DUB interaction with partners and substrates, in cancer. Furthermore, we will discuss the impact of these recent findings in the identification of new potential tools for efficient anticancer treatment strategies.
Regulation of SUMOylation Targets Associated With Wnt/beta-Catenin Pathway

Linlin Fan,Xudong Yang,Minying Zheng,Xiaohui Yang,Yidi Ning,Ming Gao,Shiwu Zhang

DOI: https://doi.org/10.3389/fonc.2022.943683

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:Wnt/beta-catenin signaling is a delicate and complex signal transduction pathway mediated by multiple signaling molecules, which plays a significant role in regulating human physiology and pathology. Abnormally activated Wnt/beta-catenin signaling pathway plays a crucial role in promoting malignant tumor occurrence, development, recurrence, and metastasis, particularly in cancer stem cells. Studies have shown that the Wnt/beta-catenin signaling pathway controls cell fate and function through the transcriptional and post-translational regulation of omics networks. Therefore, precise regulation of Wnt/beta-catenin signaling as a cancer-targeting strategy may contribute to the treatment of some malignancies. SUMOylation is a post-translational modification of proteins that has been found to play a major role in the Wnt/beta-catenin signaling pathway. Here, we review the complex regulation of Wnt/beta-catenin signaling by SUMOylation and discuss the potential targets of SUMOylation therapy.
SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition

Qi Su,Xu Chen,Xing Ling,Danqing Li,Xiang Ren,Yang Zhao,Yanyan Yang,Yuhang Liu,Anqi He,Xinjie Zhu,Xinyi Yang,Wenbin Lu,Hongmei Wu,Yitao Qi

DOI: https://doi.org/10.1016/j.jbc.2023.105244

IF: 5.485

2023-09-01

Journal of Biological Chemistry

Abstract:Endothelial-mesenchymal transition (EndoMT) is a complex biological process in which endothelial cells are transformed into mesenchymal cells, and dysregulated EndoMT causes a variety of pathological processes. Transforming growth factor beta (TGF-β) signaling effectively induces the EndoMT process in endothelial cells, and Smad2 is the critical protein of the TGF-β signaling pathway. However, whether small ubiquitin-like modifier modification (SUMOylation) is involved in EndoMT remains unclear. Here, we show that Smad2 is predominantly modified by SUMO1 at two major SUMOylation sites with PIAS2α as the primary E3 ligase, whereas SENP1 (sentrin/SUMO-specific protease 1) mediates the deSUMOylation of Smad2. In addition, we identified that SUMOylation significantly enhances the transcriptional activity and protein stability of Smad2, regulating the expression of downstream target genes. SUMOylation increases the phosphorylation of Smad2 and the formation of the Smad2-Smad4 complex, thus promoting the nuclear translocation of Smad2. Ultimately, the wildtype, but not SUMOylation site mutant Smad2 facilitated the EndoMT process. More importantly, TGF-β enhances the nuclear translocation of Smad2 by enhancing its SUMOylation and promoting the EndoMT process. These results demonstrate that SUMOylation of Smad2 plays a critical role in the TGF-β-mediated EndoMT process, providing a new theoretical basis for the treatment and potential drug targets of EndoMT-related clinical diseases.

biochemistry & molecular biology
Versatile protein tag, SUMO: Its enzymology and biological function

Keun IL Kim,Sung Hee Baek,Chin Ha Chung

DOI: https://doi.org/10.1002/jcp.10100

2002-05-09

Journal of Cellular Physiology

Abstract:Small ubiquitin-related modifier (SUMO) is a member of a ubiquitin-like protein family that regulates cellular function of a variety of target proteins. SUMO and ubiquitin are synthesized as precursors that need to be processed prior to conjugation to target proteins, and their mature forms have a similar tertiary structure. The mechanism for SUMO conjugation is also analogous to that of the ubiquitin system, such as the utilization of E1, E2, and E3 cascade enzymes. However, the biological consequence of SUMO modification is quite different from that of the ubiquitin system. Whereas ubiquitination of most proteins is for the degradative pathway, SUMO modification of target proteins is involved in nuclear protein targeting, formation of subnuclear structures, regulation of transcriptional activities or DNA binding abilities of transcription factors, and control of protein stability. This review will summarize the recent progress made in the enzymology of SUMO and its biological significance.

cell biology,physiology
SUMOylation Homeostasis in Tumorigenesis

Meng Xie,Jie Yu,Shengfang Ge,Jian Huang,Xianqun Fan

DOI: https://doi.org/10.1016/j.canlet.2019.11.004

IF: 9.756

2020-01-01

Cancer Letters

Abstract:Small ubiquitin-like modifier (SUMO), a critical regulatory modification protein, is involved in various biological processes, such as gene expression, genome maintenance and DNA damage repair (DDR). Numerous recent studies have revealed that disturbed SUMOylation and deSUMOylation homeostasis contribute to tumorigenesis. Abnormal alterations of key factors in the SUMO modification are closely related to cancer development and progression, indicating that the restoration of SUMOylation homeostasis may serve as a promising therapeutic strategy. In this review, we summarize the process and function of SUMOylation, clarify the 'dual-edged sword' functions of SUMOylation in diversified cancers and put forth future research prospects.
Emerging Role of SUMOylation in Plant Development.

Panglian Xu,Chengwei Yang

DOI: https://doi.org/10.4161/psb.24727

2013-01-01

Plant Signaling & Behavior

Abstract:Post-translational attachment of small ubiquitin-like modifier (SUMO), defined as SUMOylation, has emerged as a new mechanism of protein regulation in plant biology. In plant, SUMOylation has been shown to play crucial roles in a variety of biotic and abiotic stress responses. Recent work using viable mutants with defective SUMOylation have indicated an important role for SUMOylation in a wide range of developmental processes, such as cell division, expansion, survival and differentiation, vegetative growth and reproductive development. This review will summarize the currently emerging information regarding the function of SUMOylation in plant development.
The Regulation of TGF-β/SMAD Signaling by Protein Deubiquitination

Juan Zhang,Xiaofei Zhang,Feng Xie,Zhengkui Zhang,Hans van Dam,Long Zhang,Fangfang Zhou

DOI: https://doi.org/10.1007/s13238-014-0058-8

2014-01-01

Protein & Cell

Abstract:BSTRACT Transforming growth factor-β (TGF-β) members are key cytokines that control embryogenesis and tissue homeostasis via transmembrane TGF-β type II (TβR II) and type I (TβRI) and serine/threonine kinases receptors. Aberrant activation of TGF-β signaling leads to diseases, including cancer. In advanced cancer, the TGF-β/SMAD pathway can act as an oncogenic factor driving tumor cell invasion and metastasis, and thus is considered to be a therapeutic target. The activity of TGF-β/SMAD pathway is known to be regulated by ubiquitination at multiple levels. As ubiquitination is reversible, emerging studies have uncovered key roles for ubiquitin-removals on TGF-β signaling components by deubiquitinating enzymes (DUBs). In this paper, we summarize the latest findings on the DUBs that control the activity of the TGF-β signaling pathway. The regulatory roles of these DUBs as a driving force for cancer progression as well as their underlying working mechanisms are also discussed.
Roles of SUMOylation and De-Sumoylation in Carcinogenesis

HU Dan,CHEN Fu-xiang

DOI: https://doi.org/10.3760/cma.j.issn.1673-422x.2012.06.002

2012-01-01

Abstract:SUMO (small ubiquitin-related modifier) is involved in the post-translational modifications of proteins,and this process is referred to as SUMOylation.SUMOylation plays an important role in the regulation of cellular activities such as strengthening the stability of the protein,nucleocytoplasmic transport,DNA repair,DNA replication,mitotic and meiotic chromosome behavior,et al.SUMOylation is a dynamic process and can be reversed by SUMO-specific proteases (SENP).Once the balance between SUMOylation and de-SUMOylation is broken,there will be an aberrant expression of SUMO or SENPs in cells to happen,which may lead to the tumor occturtrence.
SUMOylation and Its Biological Function in Plants

Panglian Xu,Mianwei Zeng,Lixia Huang,Chengwei Yang

DOI: https://doi.org/10.3969/j.issn.1674-3466.2008.05.014

2008-01-01

CHINESE BULLETIN OF BOTANY

Abstract:Post-translational modification by small ubiquitin-related modifiers(SUMOs) is an important regulatory process to modulate protein function. This paper summarizes the SUMOylation pathway in plants;the pathway consists of SUMO molecules,a SUMO conjugation enzyme cascade and de-conjugation enzymes. Nascent SUMOs are processed by SUMO-specific proteases,then mature SUMOs are conjugated to substrate proteins by sequential action of three groups of enzymes:SUMO-activating enzymes(E1) ,SUMO-conjugating enzymes(E2) and SUMO-ligating enzymes(E3) . SUMOylation can be reversed by SUMO-specific proteases. SUMO modification in plants is involved in flowering induction,hormone signaling,pathogen defense and stress response.

Role of SUMOylation in Regulation of TGF-β Signaling Pathway

The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells

Protein modification by SUMO.

Signalling mechanisms and cellular functions of SUMO

Key Role for Ubiquitin Protein Modification in TGFβ Signal Transduction

Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4*

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

Regulation of Smad Functions Through Ubiquitination and Sumoylation Pathways

The Emerging Roles of SUMOylation in the Tumor Microenvironment and Therapeutic Implications

Sumoylation Enhances the Activity of the TGF-β/SMAD and HIF-1 Signaling Pathways in Keloids

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

Regulation of SUMOylation Targets Associated With Wnt/beta-Catenin Pathway

SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition

Versatile protein tag, SUMO: Its enzymology and biological function

SUMOylation Homeostasis in Tumorigenesis

Emerging Role of SUMOylation in Plant Development.

The Regulation of TGF-β/SMAD Signaling by Protein Deubiquitination

Roles of SUMOylation and De-Sumoylation in Carcinogenesis

SUMOylation and Its Biological Function in Plants